These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23698300)

  • 21. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Fogg MH; Wirth LJ; Posner M; Wang F
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3318-23. PubMed ID: 19211798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.
    Precopio ML; Sullivan JL; Willard C; Somasundaran M; Luzuriaga K
    J Immunol; 2003 Mar; 170(5):2590-8. PubMed ID: 12594286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
    Catalina MD; Sullivan JL; Bak KR; Luzuriaga K
    J Immunol; 2001 Oct; 167(8):4450-7. PubMed ID: 11591771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
    Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.
    Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F
    J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
    PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus.
    Pedneault L; Lapointe N; Alfieri C; Ghadirian P; Carpentier L; Samson J; Joncas J
    Clin Infect Dis; 1996 Oct; 23(4):806-8. PubMed ID: 8909848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
    Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
    J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.
    Marr-Belvin AK; Carville AK; Fahey MA; Boisvert K; Klumpp SA; Ohashi M; Wang F; O'Neil SP; Westmoreland SV
    Vet Pathol; 2008 Nov; 45(6):914-21. PubMed ID: 18984796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new animal model for Epstein-Barr virus pathogenesis.
    Wang F
    Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863
    [No Abstract]   [Full Text] [Related]  

  • 34. Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.
    Scherrenburg J; Piriou ER; Nanlohy NM; van Baarle D
    Clin Exp Immunol; 2008 Aug; 153(2):231-9. PubMed ID: 18549439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.
    Rivailler P; Carville A; Kaur A; Rao P; Quink C; Kutok JL; Westmoreland S; Klumpp S; Simon M; Aster JC; Wang F
    Blood; 2004 Sep; 104(5):1482-9. PubMed ID: 15150077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
    Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus.
    Cho YG; Gordadze AV; Ling PD; Wang F
    J Virol; 1999 Nov; 73(11):9206-12. PubMed ID: 10516028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of the Epstein-Barr virus nuclear antigen (EBNA-I) in oral hairy leukoplakia.
    Cruchley AT; Murray PG; Niedobitek G; Reynolds GM; Williams DM; Young LS
    Oral Dis; 1997 May; 3 Suppl 1():S177-9. PubMed ID: 9456684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.
    Heller KN; Upshaw J; Seyoum B; Zebroski H; Münz C
    Blood; 2007 Feb; 109(3):1138-46. PubMed ID: 16985171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.